Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula Hoff

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
RMD Open|December 9, 2021
Humoral protection to SARS-CoV2 declines faster in patients on TNF alpha blocking therapiesUlf M Geisen, Melike Sümbül, Florian Tran, et al.
Journal of Medical Virology|December 19, 2023
Limited antibody response after BA.4-5 adapted booster vaccination in rheumatic patients receiving anti-TNF therapy: Results of a case seriesUlf M Geisen, Mathias Voß, Ruben Rose, et al.
Annals of the Rheumatic Diseases|March 25, 2021
Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohortUlf M Geisen, Dennis K Berner, Florian Tran, et al.
Allergy|July 25, 2024
Anti-TNF therapy impairs both short- and long-term IgG responses after repeated vaccinationJana Sophia Buhre, Tamas Pongracz, Ulf Martin Geisen, et al.
Journal of Medical Virology|August 9, 2022
The long term vaccine-induced anti-SARS-CoV-2 immune response is impaired in quantity and quality under TNFα blockadeUlf Martin Geisen, Ruben Rose, Franziska Neumann, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
RMD Open|December 9, 2021
Humoral protection to SARS-CoV2 declines faster in patients on TNF alpha blocking therapiesUlf M Geisen, Melike Sümbül, Florian Tran, et al.
Journal of Medical Virology|December 19, 2023
Limited antibody response after BA.4-5 adapted booster vaccination in rheumatic patients receiving anti-TNF therapy: Results of a case seriesUlf M Geisen, Mathias Voß, Ruben Rose, et al.
Annals of the Rheumatic Diseases|March 25, 2021
Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohortUlf M Geisen, Dennis K Berner, Florian Tran, et al.
Allergy|July 25, 2024
Anti-TNF therapy impairs both short- and long-term IgG responses after repeated vaccinationJana Sophia Buhre, Tamas Pongracz, Ulf Martin Geisen, et al.
Journal of Medical Virology|August 9, 2022
The long term vaccine-induced anti-SARS-CoV-2 immune response is impaired in quantity and quality under TNFα blockadeUlf Martin Geisen, Ruben Rose, Franziska Neumann, et al.
Pageof 8